Microglia in C9orf72–associated amyotrophic lateral sclerosis: More or less active?
Björn F. Vahsen*, R. Jeroen Pasterkamp*
Oxford Motor Neuron Disease Centre, Nuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford, UK (Vahsen BF)
Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK (Vahsen BF)
Department of Translational Neuroscience, University Medical Center Utrecht Brain Center, Utrecht University, Utrecht, The Netherlands (Pasterkamp RJ)
Online:2026-09-15
Published:2026-05-12
Contact:
Björn F. Vahsen, MD, DPhil, bjorn.vahsen@ndcn.ox.ac.uk;
R. Jeroen Pasterkamp, PhD, r.j.pasterkamp@umcutrecht.nl.
Supported by:
BFV is funded by the University of Oxford Medical Sciences Division (Reference 0017772) and the Motor Neurone Disease Association Lady Edith Wolfson Junior Non-Clinical Fellowship (Vahsen/Oct25/2553-799). RJP is funded by Stichting ALS Nederland (TOTALS, ALS-on-a-chip, ATAXALS, MUSALS, GoALS), the ERANet for Research on Rare Diseases (E-rare-3: MAXOMOD and INTEGRALS), the ALS CURE project, Alzheimer Nederland and the EU Joint Program for Neurodegenerative Diseases (JPND; TRIAGE).
Björn F. Vahsen, R. Jeroen Pasterkamp. Microglia in C9orf72–associated amyotrophic lateral sclerosis: More or less active?[J]. Neural Regeneration Research, 2026, 21(9): 4253-4254.